3 completed, 2 terminated, 1 unknown. 6 Phase 2, 3 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 3, Terminated 2, Unknown 1 |
| Phase 3 | 3 | Terminated 2, Completed 1 |
| Phase 1 | 2 | Completed 2 |
Follow 2-Hydroxypropyl-beta-cyclodextrin: new trials by email Literature Review of 2-Hydroxypropyl-beta-cyclodextrin trials Research Report on 2-Hydroxypropyl-beta-cyclodextrin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease Hydroxypropyl Beta Cyclodextrin, Placebo - Alzheimer's Disease | Phase 2 | Unknown | Cyclo Therapeutics, Inc. | 90 | 2022-09-23 | 2023-04-25 |
| Open-label Study of VTS-270 in Participants With Neurologic Manifestations of Niemann-Pick Type C1 VTS-270 - Niemann-Pick Disease, Type C | Phase 2 / Phase 3 | Terminated | Mandos LLC | 2 | 2019-12-02 | 2023-12-26 |
| Study of IV VTS-270 for Infantile Liver Disease Associated With Niemann-Pick Disease, Type C VTS-270 - Niemann-Pick Disease, Type C | Phase 1 / Phase 2 | Completed | Washington University School of Medicine | 4 | 2019-02-22 | 2026-01-05 |
| Safety and Efficacy of Intravenous Trappsol Cyclo (HPBCD) in Niemann-Pick Type C Patients Hydroxypropyl-beta-cyclodextrin - Niemann-Pick Disease, Type C1 | Phase 1 / Phase 2 | Completed | Cyclo Therapeutics, Inc. | 12 | 2017-03-20 | 2021-08-10 |
| Adrabetadex to Treat Niemann-Pick Type C1 (NPC1) Disease Adrabetadex - Niemann-Pick Disease, Type C | Phase 2 / Phase 3 | Terminated | Mandos LLC | 66 | 2015-12-23 | 2023-08-29 |
| VTS-270 to Treat Niemann-Pick Type C1 (NPC1) Disease Parts A/B: Adrabetadex, Parts A/B: Sham Control - Niemann-Pick Disease, Type C | Phase 2 / Phase 3 | Completed | Mandos LLC | 56 | 2015-10-01 | 2023-02-22 |
Niemann-Pick Disease, Type C (5) · Cognitive Dysfunction (2) · Deglutition Disorders (2) · Disease (2) · Mobility Limitation (2) · Alzheimer Disease (1)
Mandos LLC (3) · Cyclo Therapeutics, Inc. (2) · Washington University School of Medicine (1)
United States (4) · United Kingdom (3) · Australia (2) · France (2) · Germany (2) · New Zealand (2) · Singapore (2) · Turkey (Türkiye) (2) · Costa Rica (1) · Israel (1) · Spain (1) · Sweden (1) · Switzerland (1)
Karen Mullen, MD (1) · Patricia I Dickson, MD (1) · Reena Sharma, MB BS (1)
2015 (2), U01HD090845 (1)